SAB Biotherapeutics
Price & Volume
Stats
See more52W Range | $1.85-$5.15 |
Market Cap | $273.7M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $114,698 |
Revenue Growth (YoY) | -62.4% |
Gross Profit (12 Mos) | -$39M |
Diluted EPS | -$0.58 |
News
See moreYahoo Finance • 11 days ago
SAB Biotherapeutics (SABS) and Breakthrough T1D Award Research Grant For SAB-142 Assessment
Yahoo Finance • 20 days ago
Why Is H.C. Wainwright Bullish On SAB Biotherapeutics (SABS) With $10 Price Target?
Yahoo Finance • 2 months ago
SAB BIO to Present Data on SAB-142 at The American Diabetes Association’s 2026 Scientific Sessions and FOCIS 2026 Annual Meeting
Yahoo Finance • 4 months ago
SAB Biotherapeutics slips 5%, prices $85M stock offering
About
CEO | Mr. Samuel J. Reich |
CFO | Ms. Lucy To |
Address | 777 W 41st St., Miami Beach, FL, United States, 33140 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 86 |